114 related articles for article (PubMed ID: 22723099)
1. Production of human or humanized antibodies in mice.
Laffleur B; Pascal V; Sirac C; Cogné M
Methods Mol Biol; 2012; 901():149-59. PubMed ID: 22723099
[TBL] [Abstract][Full Text] [Related]
2. Rearrangement of only one human IGHV gene is sufficient to generate a wide repertoire of antigen specific antibody responses in transgenic mice.
Suárez E; Magadán S; Sanjuán I; Valladares M; Molina A; Gambón F; Díaz-Espada F; González-Fernández A
Mol Immunol; 2006 Apr; 43(11):1827-35. PubMed ID: 16343622
[TBL] [Abstract][Full Text] [Related]
3. The diversity of antigen-specific monoclonal antibodies from transgenic mice bearing human immunoglobulin gene miniloci.
Wagner SD; Popov AV; Davies SL; Xian J; Neuberger MS; Brüggemann M
Eur J Immunol; 1994 Nov; 24(11):2672-81. PubMed ID: 7957560
[TBL] [Abstract][Full Text] [Related]
4. Antigen-specific human monoclonal antibodies from transgenic mice.
Mompó SM; González-Fernández A
Methods Mol Biol; 2014; 1060():245-76. PubMed ID: 24037845
[TBL] [Abstract][Full Text] [Related]
5. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD
Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969
[TBL] [Abstract][Full Text] [Related]
6. Human antibody production in transgenic animals.
Brüggemann M; Osborn MJ; Ma B; Hayre J; Avis S; Lundstrom B; Buelow R
Arch Immunol Ther Exp (Warsz); 2015 Apr; 63(2):101-8. PubMed ID: 25467949
[TBL] [Abstract][Full Text] [Related]
7. Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.
Beidler CB; Ludwig JR; Cardenas J; Phelps J; Papworth CG; Melcher E; Sierzega M; Myers LJ; Unger BW; Fisher M
J Immunol; 1988 Dec; 141(11):4053-60. PubMed ID: 3141512
[TBL] [Abstract][Full Text] [Related]
8. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
9. [Transgenesis and humanization of murine antibodies].
Cogné M; Duchez S; Pascal V
Med Sci (Paris); 2009 Dec; 25(12):1149-54. PubMed ID: 20035696
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs.
Green LL; Hardy MC; Maynard-Currie CE; Tsuda H; Louie DM; Mendez MJ; Abderrahim H; Noguchi M; Smith DH; Zeng Y; David NE; Sasai H; Garza D; Brenner DG; Hales JF; McGuinness RP; Capon DJ; Klapholz S; Jakobovits A
Nat Genet; 1994 May; 7(1):13-21. PubMed ID: 8075633
[TBL] [Abstract][Full Text] [Related]
11. Endogenous Ig production in mu transgenic mice. II. Anti-Ig reactivity and apparent double allotype expression.
Imanishi-Kari T; Huang CA; Iacomini J; Yannoutsos N
J Immunol; 1993 Apr; 150(8 Pt 1):3327-46. PubMed ID: 8468474
[TBL] [Abstract][Full Text] [Related]
12. Antigen-Specific Human Monoclonal Antibodies from Transgenic Mice.
Mompó SM; González-Fernández Á
Methods Mol Biol; 2019; 1904():253-291. PubMed ID: 30539474
[TBL] [Abstract][Full Text] [Related]
13. Repertoire diversification in mice with an IgH-locus-targeted transgene for the rearranged VH domain of a physiologically selected anti-ssDNA antibody.
Li J; Geissal ED; Li W; Stollar BD
Mol Immunol; 2005 Aug; 42(12):1475-84. PubMed ID: 15950740
[TBL] [Abstract][Full Text] [Related]
14. Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.
Major JG; Liou RS; Sun LK; Yu LM; Starnes SM; Fung MS; Chang TW; Chang NT
Hum Antibodies Hybridomas; 1994; 5(1-2):9-17. PubMed ID: 7858187
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
[TBL] [Abstract][Full Text] [Related]
16. Chimeric antibodies.
Kurosawa K; Lin W; Ohta K
Methods Mol Biol; 2014; 1060():139-48. PubMed ID: 24037840
[TBL] [Abstract][Full Text] [Related]
17. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
19. The application of transgenic mice for therapeutic antibody discovery.
Lee EC; Owen M
Methods Mol Biol; 2012; 901():137-48. PubMed ID: 22723098
[TBL] [Abstract][Full Text] [Related]
20. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice.
Mendez MJ; Green LL; Corvalan JR; Jia XC; Maynard-Currie CE; Yang XD; Gallo ML; Louie DM; Lee DV; Erickson KL; Luna J; Roy CM; Abderrahim H; Kirschenbaum F; Noguchi M; Smith DH; Fukushima A; Hales JF; Klapholz S; Finer MH; Davis CG; Zsebo KM; Jakobovits A
Nat Genet; 1997 Feb; 15(2):146-56. PubMed ID: 9020839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
